Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors - Drug Trials For Money - Paid Clinical Trials

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
Conditions:   Advanced Solid Tumor;   Ovarian Cancer;   Ovary Cancer;   Cancer of Ovary;   Cancer of the Ovary;   Ovary Neoplasm;   Pancreatic Cancer;   Pancreas Cancer;   Cancer of Pancreas;   Cancer of the Pancreas;   Pancreas Neoplasm;   Prostate Cancer;   Prostatic Cancer;   Cancer of Prostate;   Cancer of the Prostate;   Prostate Neoplasm;   Castrate Resistant Prostate Cancer;   Castration Resistant Prostatic Cancer;   Castration Resistant Prostatic Neoplasms;   Triple-negative Breast Cancer;   Triple Negative Breast Cancer;   Triple Negative Breast Neoplasms;   Breast Cancer;   Breast Carcinoma;   Cancer of Breast;   Cancer of the Breast;   Breast Tumor
Interventions:   Drug: NUV-868;   Drug: Olaparib;   Drug: Enzalutamide
Sponsor:   Nuvation Bio Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 30, 2022 / by / in
Comments